Page 6,652«..1020..6,6516,6526,6536,654..6,6606,670..»

Mesenchymal Stem Cell Research Activity Rose 116% in 2011; Businesses Turning to BioInformant Worldwide for MSC Market …

Posted: Published on July 26th, 2012

FARMINGTON, Conn., July 25, 2012 /PRNewswire-iReach/ -- Businesses looking to capture a larger slice of the lucrative mesenchymal stem cell product market need the best market research to stay ahead of the competition. Global Information Inc, in partnership with research firm BioInformant Worldwide, is pleased to present three new reports on stem cells and regenerative medicine. This new research will help businesses in the stem cell industry understand their customers by providing insight into the needs of research scientists; boost effective product development decisions; streamline marketing budgets; learn how to gain more market share; understand the key strengths and weaknesses of competitors and identify opportunities. (Logo: http://photos.prnewswire.com/prnh/20120725/CG46150) Mesenchymal Stem Cells Advances & Applications In BioInformant's recently launched market report, analysis of grant activity, publications, and patent applications reveals that Mesenchymal Stem Cell (MSC) research activity increased 112% from 2009 to 2010, and 116% from 2010 to 2011. Mesenchymal stem cells now represent fastest growing area of stem cell research. While competitors are guessing, this report divulges exactly where to focus R&D and marketing spend to create the most profitable MSC research products. The new report identifies recent advances in MSC research applications, explores research priorities by market segment, highlights individual … Continue reading →

Posted in Stem Cell Research | Comments Off on Mesenchymal Stem Cell Research Activity Rose 116% in 2011; Businesses Turning to BioInformant Worldwide for MSC Market …

Genetics Policy Institute Collaborates On Second Midwest Conference On Stem Cell Biology At Oakland U

Posted: Published on July 26th, 2012

PALM BEACH, Fla. The Genetics Policy Institute announced that it has joined with the Oakland University William Beaumont Institute for Stem Cell and Regenerative Medicine as an organizing partner of the Second Midwest Conference on Stem Cell Biology and Therapy Oct. 5-7 at Oakland University in Rochester. GPIis proud to partner with ISCRMin this important scientific conference, which will showcase the latest discoveries from top laboratories around the region and beyond, said Bernard Siegel, GPIexecutive director and founder of the annual World Stem Cell Summit. We take pride that ISCRMwas officially launched at our 2010 World Stem Cell Summit in Detroit. GPIs support for this conference underscores our continuing commitment to advance stem cell research in the Midwest. Researchers from hospitals, medical organizations, academic institutions and the business community throughout the country will discuss not only the latest advances in this rapidly expanding field of medical science, but the ethical and moral issues that surround it. There are unlimited opportunities in the rapidly progressing areas of stem cell biology and regenerative medicine, said Dr. RasulChaudhry, director of the ISCRM. This conference is a great way to showcase not only Oakland University, Beaumont Health System, and ISCRM but the strength of … Continue reading →

Comments Off on Genetics Policy Institute Collaborates On Second Midwest Conference On Stem Cell Biology At Oakland U

Ruling frees FDA to crack down on stem cell clinics

Posted: Published on July 26th, 2012

Peter Aldhous, San Francisco bureau chief It's official: stem cells are drugs. At least, that's the opinion of the US district court in Washington DC, which has ruled that the Food and Drug Administration (FDA) has the authority to regulate clinics offering controversial stem cell therapies. Treatments in which stem cells are harvested from bone marrow and injected straight back into the same patient are deemed part of routine medical practice - not regulated by the US government. But if the cells are subjected to more than "minimal manipulation", the FDA maintains that the therapy becomes a "drug", which must be specifically approved for use. It was on this basis that in 2008 the FDA began moves to shut downRegenerative Sciences, a clinic in Broomfield, Colorado, that treats orthopaedic problems using a stem cell therapy called Regenexx. Regenerative Sciences challenged the FDA's authority to regulate its activities, setting the stage for a legal fight. In 2010, the FDA sought an injunction to take Regenexx off the market. This has now been granted in the court's ruling. Christopher Centeno, medical director of Regenerative Sciences, vows to appeal. "This is really round one," he says. "Our position remains that a patient's cells … Continue reading →

Comments Off on Ruling frees FDA to crack down on stem cell clinics

Ruling frees FDA to crack down on stem cell clinics

Posted: Published on July 26th, 2012

Peter Aldhous, San Francisco bureau chief It's official: stem cells are drugs. At least, that's the opinion of the US District Court in Washington DC, which has ruled that the Food and Drug Administration (FDA) has the authority to regulate clinics offering controversial stem cell therapies. Treatments in which stem cells are harvested from bone marrow and injected straight back into the same patient are deemed part of routine medical practice - not regulated by the US government. But if the cells are subjected to more than "minimal manipulation", the FDA maintains that the therapy becomes a "drug", which must be specifically approved for use. Christopher Centeno, medical director of Regenerative Sciences, vows to appeal. "This is really round one," he says. "Our position remains that a patient's cells are not drugs." Scott hopes that the FDA will now step up its efforts to regulate other clinics offering unproven stem cell therapies. These include Celltex of Sugar Land, Texas, which rose to prominence after Texas governor Rick Perry was injected with stem cells supplied by the company to aid his recovery from back surgery. Read the rest here: Ruling frees FDA to crack down on stem cell clinics … Continue reading →

Posted in Cell Therapy | Comments Off on Ruling frees FDA to crack down on stem cell clinics

Get Cialis Without Prescriptions

Posted: Published on July 26th, 2012

Por MANUEL ERNESTO RIVERA SAN JUAN, Puerto Rico jueves 27-(AP)- El gobernador de Puerto Rico, Anbal Acevedo Vila, fue acusado de 19 cargos criminales federales por presuntas irregularidades en sus campaas polticas. La fiscal federal Rosa Emilia Rodrguez inform que, junto al mandatario, se acus a otras 12 personas vinculadas a su Partido Popular Democrtico (PPD). "Se va a permitir que el Gobernador se entregue, por deferencia al cargo que ocupa", dijo Rodrguez en conferencia de prensa. Algunos de los restantes acusados fueron arrestados el jueves. Entre los cargos radicados contra el grupo, figuran conspiracin para violar la Ley federal de Campaas Electorales, someter informes falsos a la Comisin federal de Elecciones, transferencia electrnica fraudulenta de fondos, conspiracin para defraudar al Servicio de Rentas Internas federal, rendir planillas fraudulentas y falsos testimonios al Bur Federal de Investigaciones. El abogado del gobernador Anbal Acevedo Vil catalog el jueves las acusaciones contra el mandatario como una "intromisin sin precedentes" de las autoridades federales en los asuntos internos de Puerto Rico. Green asegur que se enter de las acusaciones a eso de las 6:30 de la maana del jueves cuando un representante de la fiscala estadounidense en la isla lo llam a Washington … Continue reading →

Posted in Prescriptions | Comments Off on Get Cialis Without Prescriptions

Many dangerous drugs remain legal after 'bath salts' ban

Posted: Published on July 26th, 2012

Posted: 7:20 AM Updated: 6:31 PM The Associated Press WASHINGTON People are inventing so many new ways to get high that lawmakers can't seem to keep up. click image to enlarge This Jan. 26, 2011, photo shows containers of bath salts in Mechanicsburg, Pa. There's been a surge in the use of synthetic drugs that are made of legal chemicals but mimic the dangerous effects of cocaine, amphetamines and other illegal stimulants. The drugs, which are often sold at corner stores as bath salts, incense and plant food for as little as $15, can trigger bizarre and violent behavior. AP/The Patriot-News, Chris Knight click image to enlarge In this Friday, Jan. 29, 2011, file photo, packages of fake "bath salts," synthetic stimulants that mimic the effects of traditional drugs like cocaine and speed, are displayed by Senate Drug Policy Committee chairman Sid Albritton, R-Picayune, at the Capitol in Jackson, Miss. On July 10, 2012, President Obama signed a law banning more than two dozen of the most common chemicals used to make the drugs. Over the past two years health care and law enforcement professionals have seen a surge in use of the drugs, often sold under the guise of … Continue reading →

Posted in Drugs | Comments Off on Many dangerous drugs remain legal after 'bath salts' ban

Pharmacy profession supports new agreement

Posted: Published on July 26th, 2012

The Pharmacy Guild of New Zealand (the Guild) is delighted that all community pharmacies, including their members, have signed the new Pharmacy Services Agreement (PSA). Pharmacists are highly trained health professionals and the new Agreement allows them to work at the top of their scope of practice. The PSA is the agreement between pharmacy owners and their local District Health Board (DHB). It has been consulted on with the DHBs and sector agents, including the Guild, over the last 18 months and holds the biggest change in services and funding the profession has had in over 50 years. "As a membership organisation representing community pharmacy owners, we are very pleased that all of our 675 members have signed the PSA," says the Guild's Executive Chair, Karen Crisp. "Pharmacists currently provide many services for their patients that will be better recognised under the new Agreement." On 1 July 2012, community pharmacy began the three year transitional PSA which enables pharmacy to make better use of their clinical skills and expertise within the primary health care team. The PSA intends to move pharmacy from being paid solely by a medicine dispensing fee, to a patient-focused payment model. The new Agreement rewards pharmacists … Continue reading →

Posted in Pharmacy | Comments Off on Pharmacy profession supports new agreement

StemCell RegenMed Targets Incurable Eye Diseases

Posted: Published on July 26th, 2012

AVENTURA, July 25, 2012 (GLOBE NEWSWIRE) -- via PRWEB - Dr.Burton Feinerman of StemCell RegenMed announces the recruitment of patients diagnosed with Retinitis Pigmentosa, Age related Macular Degeneration and Stargardt Macular Degeneration. Patients with these diseases face the development of blindness at varying age levels. Burton Feinerman, M.D., a graduate of New York Medical College and a post Fellow at the Mayo Clinic, is the lead scientist who has developed this innovative combined stem cell and gene therapy. In addition, Gregg Kokame, M.D., who trained at the famous Bascom Palmer Eye Institute, Miami, Florida and Jose Fernando Rocha, M.D. who trained at the Stein Eye Institute in L.A.,California, both retina eye specialists, will be involved with insertion of stem cells and gene agents in the subretina space of the affected patients. The first patients include an eleven year old girl; a nineteen year old woman, both with Stargardt disease (juvenile macular degeneration) and a man who is sixty years old with blindness due to Retinitis Pigmentosa. Retinitis Pigmentosa is the most common inherited disease of the retina. There is initially night vision loss, followed by peripheral vision loss then tunnel vision and later central vision loss. The genes most commonly … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on StemCell RegenMed Targets Incurable Eye Diseases

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study : The Lancet

Posted: Published on July 26th, 2012

Background Stem-cell-based, tissue engineered transplants might offer new therapeutic options for patients, including children, with failing organs. The reported replacement of an adult airway using stem cells on a biological scaffold with good results at 6 months supports this view. We describe the case of a child who received a stem-cell-based tracheal replacement and report findings after 2 years of follow-up. A 12-year-old boy was born with long-segment congenital tracheal stenosis and pulmonary sling. His airway had been maintained by metal stents, but, after failure, a cadaveric donor tracheal scaffold was decellularised. After a short course of granulocyte colony stimulating factor, bone marrow mesenchymal stem cells were retrieved preoperatively and seeded onto the scaffold, with patches of autologous epithelium. Topical human recombinant erythropoietin was applied to encourage angiogenesis, and transforming growth factor to support chondrogenesis. Intravenous human recombinant erythropoietin was continued postoperatively. Outcomes were survival, morbidity, endoscopic appearance, cytology and proteomics of brushings, and peripheral blood counts. The graft revascularised within 1 week after surgery. A strong neutrophil response was noted locally for the first 8 weeks after surgery, which generated luminal DNA neutrophil extracellular traps. Cytological evidence of restoration of the epithelium was not evident until 1 year. The … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study : The Lancet

Gov. Beshear signs order to regulate prescriptions

Posted: Published on July 25th, 2012

FRANKFORT, Ky. - Kentucky Gov. Steve Beshear has signed emergency regulations that require doctors to meet tougher prescription standards in an effort to stop drug abuse. The rules, which were given to given to state boards that oversee the medical industry on Friday, were presented to lawmakers Monday and will remain in effect until permanent regulations are adopted. The Courier-Journal reports that under the order, pain clinics will face more regulations and doctors are required to use the state's prescription drug tracking system. Some physicians have raised concerns that the order exceeds the original goal of a bill passed by lawmakers, but Beshear said in a prepared statement that his office worked diligently to make sure the emergency regulations match the intent of the bill. "Everyone's ultimate goal is to reduce the abuse and diversion of prescription drugs, and these regulations are a necessary step in effecting that change," he said. "The regulations are built to protect legitimate patient needs and proper prescribing habits. Only those who abuse the system have anything to fear." The statute passed by lawmakers didn't spell out new regulations. Instead, it said licensing boards should "police their own industry" and gave them until Sept. 1 … Continue reading →

Posted in Prescriptions | Comments Off on Gov. Beshear signs order to regulate prescriptions

Page 6,652«..1020..6,6516,6526,6536,654..6,6606,670..»